1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Deal-Making Trends in Pharma - Thematic Research

Deal-Making Trends in Pharma - Thematic Research

  • September 2019
  • 56 pages
  • ID: 5824463
  • Format: PDF
  • GlobalData


Table of Contents

Search Inside

Deal-Making Trends in Pharma - Thematic Research

To gain a better understanding of the pharmaceutical deal landscape, this report will dive into three separate deal categories: strategic partnerships, licensing activity, and M&A activity.Furthermore, the categories will be further broken down by four dominating therapeutic themes.

These include gene therapy, immuno-oncology, microbiome, and orphan drugs.

These themes are among those expected to have the greatest presence in deals made within the pharmaceutical industry, which is indicative of the optimism surrounding their future potential.Please also note that this report only covers select geographies, North America, Europe, and Asia-Pacific, the three regions with the highest deal volume and value.

These regions were also chosen to be covered in this report based on the fact that they are hotspots for the development of innovative drugs.
This report also identifies target drug companies that would be strong acquisition target candidates.

The companies identified include those that have drugs that fall into one of the four major themes discussed in this report: gene therapy, immuno-oncology, microbiome, and/or orphan drugs.Chosen targets were also selected on the basis of having drugs in both the preclinical stage and clinical stage settings.

Identified targets are also all privately owned, and have seen little to no recent merger and acquisition (M&A) activity in the past five years. Lastly, the list of targets also includes those have had recent positive clinical trial data.

Deal-Making Trends in Pharma report provides with in-house expertise to provide an assessment of the deal landscape within the pharmaceutical industry.

Components of the report include -
- Data analysis, trends, and insights for strategic partnerships, licensing activity, and M&A activity within the pharmaceutical industry
- Data analysis, trends, and insights for deals that encompass specific therapeutic themes (gene therapy, immuno-oncology, microbiome, and orphan drugs)
- Data analysis, trends, and insights for deals that have occurred in select geographies (North America, Europe, and Asia-Pacific)
- Identification of drug companies that would be strong acquisition target candidates

Reasons to buy
- Gain a better understating of the volume and value dynamics within the pharmaceutical deal space.
Develop and design your corporate strategies through an in-house expert analysis of deals impacting the healthcare industry.
- Stay up to date on the industry’s most impactful deals that have been completed within the past 5 years, along with a glimpse of deals completed or to be completed in 2019.
- Identify emerging deal trends, as they relate to deal type, therapeutic theme, geography, to gain a competitive advantage.
- Identify drug companies that would be strong acquisition target candidates.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on